Peptides, devices, and methods for the detection of
The invention provides populations of isolated peptides useful for the detection of antibodies that bind to Anaplasma antigens. The peptide populations comprise peptides derived from immunogenic fragments of the Anaplasma Outer Membrane Protein proteins. The invention also provides devices, methods, and kits comprising the populations of isolated peptides useful for the detection of antibodies that bind to Anaplasma antigens and the diagnosis of anaplasmosis. Methods of identifying the particular Anaplasma species infecting a subject using the peptide populations of the invention are also disclosed.
1. A composition comprising a population of isolated peptides, said population comprising three or more different peptides, wherein at least one peptide in the population comprises the sequence of SEQ ID NO; 6, and wherein the population further comprises two or more different peptides selected from:
(i) SEQ ID NO: 1 or a fragment thereof, wherein X 9 is an amino acid selected from the group consisting of I, P and H, X 17 is an amino acid selected from the group consisting of I, W, and Y, X 21 is an amino acid selected from the group consisting of R, D, and N, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V;
(ii) SEQ ID NO: 2 or a fragment thereof, wherein X 3 is an amino acid selected from the group consisting of L, V and A, X 7 is an amino acid selected from the group consisting of K, N and Q, X 11 is an amino acid selected from the group consisting of R, D, and N, and X 15 is an amino acid selected from the group consisting of E, N and Q;
(iii) SEQ ID NO: 3 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of V and A, X 7 is an amino acid selected from the group consisting of G, I and H, X 11 is an amino acid selected from the group consisting of E, N, and Q, X 18 is an amino acid selected from the group consisting of D and N, X 21 is an amino acid selected from the group consisting of R, D, and N, X 25 is an amino acid selected from the group consisting of Q, D, and E, X 28 is an amino acid selected from the group consisting of E and N, X 31 is an amino acid selected from the group consisting of L and V, X 45 is an amino acid selected from the group consisting of K and Q, X 48 is an amino acid selected from the group consisting of F and V, X 51 is an amino acid selected from the group consisting of D and N, X 54 is an amino acid selected from the group consisting of E and Q, X 57 is an amino acid selected from the group consisting of S and Q, X 60 is an amino acid selected from the group consisting of F and W, X 63 is an amino acid selected from the group consisting of I and V, and X 66 is an amino acid selected from the group consisting of Q and D;
(iv) SEQ ID NO: 4 or a fragment thereof, wherein X 6 is an amino acid selected from the group consisting of K and Q, X 9 is an amino acid selected from the group consisting of F and V, X 12 is an amino acid selected from the group consisting of D and N, X 15 is an amino acid selected from the group consisting of E and Q, X 18 is an amino acid selected from the group consisting of S and Q, X 21 is an amino acid selected from the group consisting of F and W, X 24 is an amino acid selected from the group consisting of I and V, and X 27 is an amino acid selected from the group consisting of Q and D;
(v) SEQ ID NO: 5 or a fragment thereof, wherein X 2 is an amino acid selected from the group consisting of I and V, X 10 is an amino acid selected from the group consisting of S and Y, and X 23 is an amino acid selected from the group consisting of E and N;
(vi) SEQ ID NO: 7 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of S and Q, X 9 is an amino acid selected from the group consisting of F and Y, X 13 is an amino acid selected from the group consisting of R and H, X 16 is an amino acid selected from the group consisting of W and Y, X 18 is an amino acid selected from the group consisting of S and Q, X 22 is an amino acid selected from the group consisting of K and H, and X 27 is an amino acid selected from the group consisting of N and D;
(vii) SEQ ID NO: 8 or a fragment thereof, wherein X 10 is an amino acid selected from the group consisting of V, L and I, and X 11 is an amino acid selected from the group consisting of A and L; and
(viii) SEQ ID NO: 9 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of V and A, X 7 is an amino acid selected from the group consisting of G, I and H, X 11 is an amino acid selected from the group consisting of E, N, and Q, X 21 is an amino acid selected from the group consisting of R, D, and N, X 25 is an amino acid selected from the group consisting of Q, D, and E, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V.
2. The composition of claim 1 , wherein one or more of the peptides is conjugated to a ligand.
3. The composition of claim 1 , wherein one or more of the peptides is conjugated to biotin, avidin, streptavidin, neutravidin, serum albumin, keyhole limpet hemocyanin (KLH), an enzyme, or a metallic nanomaterial.
4. The composition of claim 1 , wherein the population of peptides is immobilized to a solid support optionally through a metallic nanolayer.
5. The composition of claim 4 , wherein the solid support is a plurality of beads, a flow path in a lateral flow immunoassay device, a well in a microtiter plate, or a flow path in a rotor.
6. The composition of claim 1 , wherein the fragment is at least 15, 20, 25, 30, 35, 40, 45, 50, 55, or 60 amino acids long.
7. The composition of claim 1 , wherein the composition further comprises one or more antigenic peptides from an Anaplasma species, an Ehrlichia species, and/or a Borrelia species.
8. The composition of claim 1 ,wherein at least one of the two or more different peptides comprises SEQ ID NO: 3.
9. The composition of claim 1 , wherein the two or more different peptides comprise SEQ ID NO: 3 and SEQ ID NO: 7.
10. A kit comprising the composition of claim 1 and a labeling reagent capable of binding to an antibody that recognizes an epitope of one or more peptides in the composition.
11. The kit of claim 10 , wherein the peptides in the composition are attached to or immobilized on a solid support optionally through a metallic nanolayer.
12. The kit of claim 10 , wherein the labeling reagent is an anti-human, anti-canine, or anti-feline IgG or IgM antibody conjugated to a detectable label.
13. The kit of claim 12 , wherein the detectable label is an enzyme, a metallic nanoparticle, metallic nanoshell, metallic nanolayer, fluorophore, or colored latex particle.
14. The kit of claim 10 , wherein the labeling reagent is protein A, protein G, and/or a protein A/G fusion protein conjugated to a detectable label.
15. The kit of claim 14 , wherein the detectable label is an enzyme, a metallic nanoparticle, metallic nanoshell, metallic nanolayer, fluorophore, or colored latex particle.
16. A composition comprising a population of isolated peptides, said population comprising three or more different peptides, wherein at least one peptide in the population comprises the sequence of SEQ ID NO: 3, and wherein the population further comprises two or more different peptides selected from:
(i) SEQ ID NO: 1 or a fragment thereof, wherein X 9 is an amino acid selected from the group consisting of I, P and H, X 17 is an amino acid selected from the group consisting of I, W, and Y, X 21 is an amino acid selected from the group consisting of R, D, and N, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V;
(ii) SEQ ID NO: 2 or a fragment thereof, wherein X 3 is an amino acid selected from the group consisting of L, V and A, X 7 is an amino acid selected from the group consisting of K, N and Q, X 11 is an amino acid selected from the group consisting of R, D, and N, and X 15 is an amino acid selected from the group consisting of E, N and Q;
(iii) SEQ ID NO: 4 or a fragment thereof, wherein X6 is an amino acid selected from the group consisting of K and Q, X 9 is an amino acid selected from the group consisting of F and V, X 12 is an amino acid selected from the group consisting of D and N, X 15 is an amino acid selected from the group consisting of E and Q, X 18 is an amino acid selected from the group consisting of S and Q, X 21 is an amino acid selected from the group consisting of F and W, X 24 is an amino acid selected from the group consisting of I and V, and X 27 is an amino acid selected from the group consisting of Q and D;
(iv) SEQ ID NO: 5 or a fragment thereof, wherein X 2 is an amino acid selected from the group consisting of I and V, X 10 is an amino acid selected from the group consisting of S and Y, and X 23 is an amino acid selected from the group consisting of E and N;
(v) SEQ ID NO: 6 or a fragment thereof;
(vi) SEQ ID NO: 7 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of S and Q, X 9 is an amino acid selected from the group consisting of F and Y, X 13 is an amino acid selected from the group consisting of R and H, X 16 is an amino acid selected from the group consisting of W and Y, X 18 is an amino acid selected from the group consisting of S and Q, X 22 is an amino acid selected from the group consisting of K and H, and X 27 is an amino acid selected from the group consisting of N and D;
(vii) SEQ ID NO: 8 or a fragment thereof, wherein X 10 is an amino acid selected from the group consisting of V, L and I, and X 11 is an amino acid selected from the group consisting of A and L; and
(viii) SEQ ID NO: 9 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of V and A, X 7 is an amino acid selected from the group consisting of G, I and H, X 11 is an amino acid selected from the group consisting of E, N, and Q, X 21 is an amino acid selected from the group consisting of R, D, and N, X 25 is an amino acid selected from the group consisting of Q, D, and E, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V.
17. A composition comprising a population of isolated peptides, said population comprising three or more different peptides, wherein at least one peptide in the population comprises the sequence of SEQ ID NO: 7, and wherein the population further comprises two or more different peptides selected from:
(i) SEQ ID NO: 1 or a fragment thereof, wherein X 9 is an amino acid selected from the group consisting of I, P and H, X 17 is an amino acid selected from the group consisting of I, W, and Y, X 21 is an amino acid selected from the group consisting of R, D, and N, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V;
(ii)SEQ ID NO: 2 or a fragment thereof, wherein X 3 is an amino acid selected from the group consisting of L, V and A, X 7 is an amino acid selected from the group consisting of K, N and Q, X 11 is an amino acid selected from the group consisting of R, D, and N, and X 15 is an amino acid selected from the group consisting of E, N and Q;
(iii) SEQ ID NO: 3 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of V and A, X 7 is an amino acid selected from the group consisting of G, I and H, X 11 is an amino acid selected from the group consisting of E, N, and Q, X 18 is an amino acid selected from the group consisting of D and N, X 21 is an amino acid selected from the group consisting of R, D, and N, X 25 is an amino acid selected from the group consisting of Q, D, and E, X 28 is an amino acid selected from the group consisting of E and N, X 31 is an amino acid selected from the group consisting of L and V, X 45 is an amino acid selected from the group consisting of K and Q, X 48 is an amino acid selected from the group consisting of F and V, X 51 is an amino acid selected from the group consisting of D and N, X 54 is an amino acid selected from the group consisting of E and Q, X 57 is an amino acid selected from the group consisting of S and Q, X 60 is an amino acid selected from the group consisting of F and W, X 63 is an amino acid selected from the group consisting of I and V, and X 66 is an amino acid selected from the group consisting of Q and D;
(iv) SEQ ID NO: 4 or a fragment thereof, wherein X 6 is an amino acid selected from the group consisting of K and Q, X 9 is an amino acid selected from the group consisting of F and V, X 12 is an amino acid selected from the group consisting of D and N, X 15 is an amino acid selected from the group consisting of E and Q, X 18 is an amino acid selected from the group consisting of S and Q, X 21 is an amino acid selected from the group consisting of F and W, X 24 is an amino acid selected from the group consisting of I and V, and X 27 is an amino acid selected from the group consisting of Q and D;
(v) SEQ ID NO: 5 or a fragment thereof, wherein X 2 is an amino acid selected from the group consisting of I and V, X 10 is an amino acid selected from the group consisting of S and Y, and X 23 is an amino acid selected from the group consisting of E and N;
(vi) SEQ ID NO: 6 or a fragment thereof;
(vii) SEQ ID NO: 8 or a fragment thereof, wherein X 10 is an amino acid selected from the group consisting of V, L and I, and X 11 is an amino acid selected from the group consisting of A and L; and
(viii) SEQ ID NO: 9 or a fragment thereof, wherein X 5 is an amino acid selected from the group consisting of V and A, X 7 is an amino acid selected from the group consisting of G, I and H, X 11 is an amino acid selected from the group consisting of E, N, and Q, X 21 is an amino acid selected from the group consisting of R, D, and N, X 25 is an amino acid selected from the group consisting of Q, D, and E, X 28 is an amino acid selected from the group consisting of E and N, and X 31 is an amino acid selected from the group consisting of L and V.